232 related articles for article (PubMed ID: 4134634)
1. [Treatment of thromboembolic conditions with thrombolytics and anticoagulants].
Wojczuk J
Wiad Lek; 1974 May; 27(10):877-82. PubMed ID: 4134634
[No Abstract] [Full Text] [Related]
2. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
Verstraete M
Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
[No Abstract] [Full Text] [Related]
3. [Anticoagulants].
Coelho E
Rev Hosp Clin Fac Med Sao Paulo; 1968 Jul; 23(4):217-28. PubMed ID: 4175980
[No Abstract] [Full Text] [Related]
4. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
Thiele R
Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
[No Abstract] [Full Text] [Related]
5. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents].
Gross R
Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339
[No Abstract] [Full Text] [Related]
6. [Current trends in anticoagulant and thrombolytic therapy of thrombosis].
Gavrilov OK; Rachinskaia NA; Kaveshnikova BF
Sov Med; 1975 Sep; (9):53-9. PubMed ID: 781864
[No Abstract] [Full Text] [Related]
7. [Current data on diagnosis and treatment of thromboembolic states].
Zosin P; Roth L
Med Interna (Bucur); 1972 Aug; 24(8):947-58. PubMed ID: 5080893
[No Abstract] [Full Text] [Related]
8. [When is fibrinolytic therapy indicated?].
Woitinas F
Med Klin; 1980 Feb; 75(3):98-107. PubMed ID: 6990218
[No Abstract] [Full Text] [Related]
9. [Advances in the treatment and prevention of thromboembolism].
Sas G
Orv Hetil; 1988 Mar; 129(12):591-9. PubMed ID: 3283645
[No Abstract] [Full Text] [Related]
10. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
Ruiz Manzano J; Monreal M
Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
[No Abstract] [Full Text] [Related]
11. Drugs in the treatment of thrombo-embolic diseases--Part II.
Bouchier-Hayes D
Ir Med J; 1983 Mar; 76(3):155-9. PubMed ID: 6345455
[No Abstract] [Full Text] [Related]
12. [Discontinuation of oral anticoagulant therapy following fibrinolytic treatment in arterial occlusive disease].
Engelken HJ; Martin M
Med Welt; 1974 Jun; 25(25):1122-4. PubMed ID: 4418430
[No Abstract] [Full Text] [Related]
13. Management of venous thromboembolic (VTE) disease--Part II: Treatment.
Kayser SR
Prog Cardiovasc Nurs; 1996; 11(1):36-40, 46. PubMed ID: 8657708
[No Abstract] [Full Text] [Related]
14. [Thromboembolism and fibrinolytic therapy].
Heinrichs C
Z Arztl Fortbild (Jena); 1978 Apr; 72(8):357-65. PubMed ID: 695726
[No Abstract] [Full Text] [Related]
15. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
Zabolotskikh IB; Sin'kov SV; Klevko VA
Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
[No Abstract] [Full Text] [Related]
16. Anticoagulant treatment.
Poller L
Practitioner; 1978 Aug; 221(1322):211-6. PubMed ID: 724615
[No Abstract] [Full Text] [Related]
17. Anticoagulant and thrombolytic drugs. II. Clinical aspects.
Ogston D; Douglas AS
Drugs; 1971; 1(4):303-19. PubMed ID: 4939607
[No Abstract] [Full Text] [Related]
18. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics].
Pelosio L; Marasco A; Puopolo G
Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661
[No Abstract] [Full Text] [Related]
19. [Fibrinolytic herapy of severe pulmonary hypertension. Justification, modality an criticism].
Bouvier CA; Ritschard J; Meykadeh F; Fournet P; Duchosal PW
Schweiz Med Wochenschr; 1970 Jan; 100(4):148-51. PubMed ID: 4099821
[No Abstract] [Full Text] [Related]
20. [Fibrinolytics. 46].
Wagler M
Pharm Prax; 1970; 6():141-2. PubMed ID: 4195438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
